WallStSmart
RCEL

Avita Medical Ltd

NASDAQ: RCEL · HEALTHCARE · MEDICAL DEVICES

$4.32
+2.13% today

Updated 2026-04-30

Market cap
$133.26M
P/E ratio
P/S ratio
1.86x
EPS (TTM)
$-1.74
Dividend yield
52W range
$3 – $10
Volume
0.2M

Avita Medical Ltd (RCEL) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-49.4%
Last 4 quarters
Revenue YoY growth
-4.3%
Most recent quarter
EPS YoY growth
+45.6%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+8.0%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+8.3%
2026-02-12
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-12$-0.38+0.0%$3.84$4.16+8.3%
2025-11-06$-0.71-73.6%$3.50$3.77+7.7%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.38$-0.38+0.0%$17.62M-4.3%
2025-09-30$-0.41$-0.71-73.6%$17.06M-12.7%
2025-06-30$-0.36$-0.58-61.1%$18.42M+21.2%
2025-03-31$-0.51$-0.83-62.7%$18.51M+66.7%
2024-12-31$-0.74$-0.70+6.0%$18.41M+29.7%
2024-09-30$-0.44$-0.62-40.9%$19.55M+43.2%
2024-06-30$-0.52$-0.60-15.4%$15.20M+29.3%
2024-03-31$-0.47$-0.73-55.3%$11.10M+5.3%
2023-12-31$-0.37$-0.28+24.3%$14.20M
2023-09-30$-0.44$-0.34+22.7%$13.64M
2023-06-30$-0.32$-0.41-28.1%$11.75M
2023-03-31$-0.25$-0.37-48.0%$10.55M

Frequently asked questions

Has Avita Medical Ltd beaten earnings estimates?
Avita Medical Ltd has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -49.4% over the last 4 quarters.
How does RCEL stock react to earnings?
RCEL stock has moved an average of +8.0% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.
What is Avita Medical Ltd's revenue growth rate?
Avita Medical Ltd reported year-over-year revenue growth of -4.3% in its most recent quarter, with EPS growing +45.6% year-over-year.